Search - tctmd.com

Displaying 1 - 20 of 65

Sort: Relevancy | Date

Presentation TCT 2025

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2025

TCT 1008: Aspirin vs. Clopidogrel as Monotherapy for Secondary Prevention in Stable Coronary Artery Disease: An Updated Meta Analysis

Presenter: Timothy Charles Shuey

October 27, 2025

Presentation TCT 2024

TCT 765: Lipid-Lowering Therapy in Contemporary PCI Practice

Presenter: Patrick Serruys

October 30, 2024

Presentation TCT 2024

TCT 766: Long-Acting Nitrates Before and After Revascularization of Chronic Coronary Syndrome: A Case Crossover Study From SCAAR

Presenter: Sacharias von Koch

October 30, 2024

Presentation TCT 2024

TCT 763: Trajectories of Adherence to Secondary Prevention Pharmacotherapy After Coronary Catheterization: A Retrospective Population-Based Study

Presenter: Leon Heitmann

October 30, 2024

Presentation TCT 2024

TCT 767: The Clinical Impact of Nicorandil Treatment on the Top of Standard Anti-Anginal Medications in Patients With Significant Coronary Artery Spasm up to 5 Years

Presenter: Woo Jin Ahn

October 30, 2024

Presentation TCT 2024

TCT 764: Clinical Outcomes of High Intensity Lipid Lowering Therapy in Patient Following Complex PCI

Presenter: Young-Kwan Kim

October 30, 2024

Presentation TCT 2024

The Case for Quality in Post PCI / Secondary Prevention Patients – Moving Knowledge to Action

Presenter: Jennifer Rymer

October 28, 2024

Presentation TCT 2023

Where Do Antithrombotics Fit In?

Presenter: Marc Bonaca

October 26, 2023

Presentation TCT 2023

Beyond LDL

Presenter: Pieter Smits

October 26, 2023

Presentation TCT 2023

Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i

Presenter: Eldrin Lewis

October 26, 2023

Presentation TCT 2023

Lipoprotein(a): Why Measure and What to Do?

Presenter: Sotirios Tsimikas

October 26, 2023

Applying New LDL-C Lowering Agents: Update on PCSK9mab, Inclisiran, and Bempedoic Acid

Presentation TCT 2023

Applying New LDL-C Lowering Agents: Update on PCSK9mab, Inclisaran, and Bempedoic Acid

Presenter: Karol Watson

October 26, 2023

Presentation TCT 2023

Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For?

Presenter: Amit Khera

October 26, 2023

Presentation TCT 2023

Secondary Prevention Case: Complex PCI in Stable Patient (No Prior MI)

Presenter: Lauren Ranard

October 26, 2023

Presentation TCT 2023

Current Trials Addressing Early and Aggressive Secondary Prevention

Presenter: Marc Bonaca

October 26, 2023

Presentation TCT 2023

Update on Current Treatment Targets for Secondary Prevention

Presenter: Dominick Angiolillo

October 26, 2023

Presentation TCT 2023

Secondary Prevention Needs to Be Addressed in the Cath Lab!

Presenter: Ajay Kirtane

October 26, 2023

Presentation TCT 2023

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

Presenter: Minju Han

October 25, 2023

Presentation ESC 2022

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Presenter: Valentin Fuster

August 29, 2022

Advertisement

TCT 494: Cost-Effectiveness of SGLT2 Inhibitors, Statins, and GLP-1 Receptor Agonists for Cardiovascular Secondary Prevention: A Comparative Analysis

TCT 1008: Aspirin vs. Clopidogrel as Monotherapy for Secondary Prevention in Stable Coronary Artery Disease: An Updated Meta Analysis

TCT 765: Lipid-Lowering Therapy in Contemporary PCI Practice

TCT 766: Long-Acting Nitrates Before and After Revascularization of Chronic Coronary Syndrome: A Case Crossover Study From SCAAR

TCT 763: Trajectories of Adherence to Secondary Prevention Pharmacotherapy After Coronary Catheterization: A Retrospective Population-Based Study

TCT 767: The Clinical Impact of Nicorandil Treatment on the Top of Standard Anti-Anginal Medications in Patients With Significant Coronary Artery Spasm up to 5 Years

TCT 764: Clinical Outcomes of High Intensity Lipid Lowering Therapy in Patient Following Complex PCI

The Case for Quality in Post PCI / Secondary Prevention Patients – Moving Knowledge to Action

Where Do Antithrombotics Fit In?

Beyond LDL

Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i

Lipoprotein(a): Why Measure and What to Do?

Applying New LDL-C Lowering Agents: Update on PCSK9mab, Inclisaran, and Bempedoic Acid

Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For?

Secondary Prevention Case: Complex PCI in Stable Patient (No Prior MI)

Current Trials Addressing Early and Aggressive Secondary Prevention

Update on Current Treatment Targets for Secondary Prevention

Secondary Prevention Needs to Be Addressed in the Cath Lab!

TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content